Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE ...
Anixa Biosciences Initiates Dosing In Third Cohort In Its Ovarian Cancer CAR-T Clinical Trial
Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose SAN JOSE, Calif., Nov.